The global Annuloplasty System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

An annuloplasty system is a medical device used in cardiac surgery to repair a damaged or dysfunctional heart valve, typically the mitral or tricuspid valve. The goal of annuloplasty is to restore the normal size, shape, and function of the valve's annulus, which is the ring-like structure that supports the valve leaflets.

From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Annuloplasty System leading manufacturers including Edwards Lifesciences, Medtronic, Abbott (formerly St. Jude Medical), Sorin Group (now part of LivaNova), Boston Scientific, Valtech Cardio (acquired by Edwards Lifesciences), NeoChord, Corcym, Labcor Laboratories Ltda., AFFLUENT MEDICAL, etc., dominate supply; the top five capture approximately % of global revenue, with Edwards Lifesciences leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Annuloplasty System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Annuloplasty System Market Report

Report Metric	Details
Report Name	Annuloplasty System Market
Segment by Type	Mitral Valve Repair Tricuspid Valve Repair Aortic Valve Repair
Segment by Application	Hospitals Ambulatory Surgical Centers Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Edwards Lifesciences, Medtronic, Abbott (formerly St. Jude Medical), Sorin Group (now part of LivaNova), Boston Scientific, Valtech Cardio (acquired by Edwards Lifesciences), NeoChord, Corcym, Labcor Laboratories Ltda., AFFLUENT MEDICAL, Valcare Medical, Braile Biomédica, Micro Interventional Devices, Incorporated
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Annuloplasty System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Annuloplasty System Market report?

Ans: The main players in the Annuloplasty System Market are Edwards Lifesciences, Medtronic, Abbott (formerly St. Jude Medical), Sorin Group (now part of LivaNova), Boston Scientific, Valtech Cardio (acquired by Edwards Lifesciences), NeoChord, Corcym, Labcor Laboratories Ltda., AFFLUENT MEDICAL, Valcare Medical, Braile Biomédica, Micro Interventional Devices, Incorporated

What are the Application segmentation covered in the Annuloplasty System Market report?

Ans: The Applications covered in the Annuloplasty System Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Annuloplasty System Market report?

Ans: The Types covered in the Annuloplasty System Market report are Mitral Valve Repair, Tricuspid Valve Repair, Aortic Valve Repair

1 Study Coverage

1.1 Introduction to Annuloplasty System: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Annuloplasty System Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Mitral Valve Repair

1.2.3 Tricuspid Valve Repair

1.2.4 Aortic Valve Repair

1.3 Market Segmentation by Application

1.3.1 Global Annuloplasty System Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Annuloplasty System Revenue Estimates and Forecasts 2020-2031

2.2 Global Annuloplasty System Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Annuloplasty System Sales Estimates and Forecasts 2020-2031

2.4 Global Annuloplasty System Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Annuloplasty System Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Annuloplasty System Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Mitral Valve Repair Market Size by Manufacturers

3.5.2 Tricuspid Valve Repair Market Size by Manufacturers

3.5.3 Aortic Valve Repair Market Size by Manufacturers

3.6 Global Annuloplasty System Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Annuloplasty System Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Annuloplasty System Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Annuloplasty System Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Annuloplasty System Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Annuloplasty System Sales and Revenue by Type (2020-2031)

6.4 North America Annuloplasty System Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Annuloplasty System Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Annuloplasty System Sales and Revenue by Type (2020-2031)

7.4 Europe Annuloplasty System Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Annuloplasty System Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Annuloplasty System Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Annuloplasty System Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Annuloplasty System Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Annuloplasty System Sales and Revenue by Type (2020-2031)

9.4 Central and South America Annuloplasty System Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Annuloplasty System Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Annuloplasty System Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Annuloplasty System Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Annuloplasty System Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Edwards Lifesciences

11.1.1 Edwards Lifesciences Corporation Information

11.1.2 Edwards Lifesciences Business Overview

11.1.3 Edwards Lifesciences Annuloplasty System Product Models, Descriptions and Specifications

11.1.4 Edwards Lifesciences Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Edwards Lifesciences Annuloplasty System Sales by Product in 2024

11.1.6 Edwards Lifesciences Annuloplasty System Sales by Application in 2024

11.1.7 Edwards Lifesciences Annuloplasty System Sales by Geographic Area in 2024

11.1.8 Edwards Lifesciences Annuloplasty System SWOT Analysis

11.1.9 Edwards Lifesciences Recent Developments

11.2 Medtronic

11.2.1 Medtronic Corporation Information

11.2.2 Medtronic Business Overview

11.2.3 Medtronic Annuloplasty System Product Models, Descriptions and Specifications

11.2.4 Medtronic Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Medtronic Annuloplasty System Sales by Product in 2024

11.2.6 Medtronic Annuloplasty System Sales by Application in 2024

11.2.7 Medtronic Annuloplasty System Sales by Geographic Area in 2024

11.2.8 Medtronic Annuloplasty System SWOT Analysis

11.2.9 Medtronic Recent Developments

11.3 Abbott (formerly St. Jude Medical)

11.3.1 Abbott (formerly St. Jude Medical) Corporation Information

11.3.2 Abbott (formerly St. Jude Medical) Business Overview

11.3.3 Abbott (formerly St. Jude Medical) Annuloplasty System Product Models, Descriptions and Specifications

11.3.4 Abbott (formerly St. Jude Medical) Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Abbott (formerly St. Jude Medical) Annuloplasty System Sales by Product in 2024

11.3.6 Abbott (formerly St. Jude Medical) Annuloplasty System Sales by Application in 2024

11.3.7 Abbott (formerly St. Jude Medical) Annuloplasty System Sales by Geographic Area in 2024

11.3.8 Abbott (formerly St. Jude Medical) Annuloplasty System SWOT Analysis

11.3.9 Abbott (formerly St. Jude Medical) Recent Developments

11.4 Sorin Group (now part of LivaNova)

11.4.1 Sorin Group (now part of LivaNova) Corporation Information

11.4.2 Sorin Group (now part of LivaNova) Business Overview

11.4.3 Sorin Group (now part of LivaNova) Annuloplasty System Product Models, Descriptions and Specifications

11.4.4 Sorin Group (now part of LivaNova) Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Sorin Group (now part of LivaNova) Annuloplasty System Sales by Product in 2024

11.4.6 Sorin Group (now part of LivaNova) Annuloplasty System Sales by Application in 2024

11.4.7 Sorin Group (now part of LivaNova) Annuloplasty System Sales by Geographic Area in 2024

11.4.8 Sorin Group (now part of LivaNova) Annuloplasty System SWOT Analysis

11.4.9 Sorin Group (now part of LivaNova) Recent Developments

11.5 Boston Scientific

11.5.1 Boston Scientific Corporation Information

11.5.2 Boston Scientific Business Overview

11.5.3 Boston Scientific Annuloplasty System Product Models, Descriptions and Specifications

11.5.4 Boston Scientific Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Boston Scientific Annuloplasty System Sales by Product in 2024

11.5.6 Boston Scientific Annuloplasty System Sales by Application in 2024

11.5.7 Boston Scientific Annuloplasty System Sales by Geographic Area in 2024

11.5.8 Boston Scientific Annuloplasty System SWOT Analysis

11.5.9 Boston Scientific Recent Developments

11.6 Valtech Cardio (acquired by Edwards Lifesciences)

11.6.1 Valtech Cardio (acquired by Edwards Lifesciences) Corporation Information

11.6.2 Valtech Cardio (acquired by Edwards Lifesciences) Business Overview

11.6.3 Valtech Cardio (acquired by Edwards Lifesciences) Annuloplasty System Product Models, Descriptions and Specifications

11.6.4 Valtech Cardio (acquired by Edwards Lifesciences) Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Valtech Cardio (acquired by Edwards Lifesciences) Recent Developments

11.7 NeoChord

11.7.1 NeoChord Corporation Information

11.7.2 NeoChord Business Overview

11.7.3 NeoChord Annuloplasty System Product Models, Descriptions and Specifications

11.7.4 NeoChord Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 NeoChord Recent Developments

11.8 Corcym

11.8.1 Corcym Corporation Information

11.8.2 Corcym Business Overview

11.8.3 Corcym Annuloplasty System Product Models, Descriptions and Specifications

11.8.4 Corcym Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Corcym Recent Developments

11.9 Labcor Laboratories Ltda.

11.9.1 Labcor Laboratories Ltda. Corporation Information

11.9.2 Labcor Laboratories Ltda. Business Overview

11.9.3 Labcor Laboratories Ltda. Annuloplasty System Product Models, Descriptions and Specifications

11.9.4 Labcor Laboratories Ltda. Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Labcor Laboratories Ltda. Recent Developments

11.10 AFFLUENT MEDICAL

11.10.1 AFFLUENT MEDICAL Corporation Information

11.10.2 AFFLUENT MEDICAL Business Overview

11.10.3 AFFLUENT MEDICAL Annuloplasty System Product Models, Descriptions and Specifications

11.10.4 AFFLUENT MEDICAL Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 AFFLUENT MEDICAL Recent Developments

11.11 Valcare Medical

11.11.1 Valcare Medical Corporation Information

11.11.2 Valcare Medical Business Overview

11.11.3 Valcare Medical Annuloplasty System Product Models, Descriptions and Specifications

11.11.4 Valcare Medical Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Valcare Medical Recent Developments

11.12 Braile Biomédica

11.12.1 Braile Biomédica Corporation Information

11.12.2 Braile Biomédica Business Overview

11.12.3 Braile Biomédica Annuloplasty System Product Models, Descriptions and Specifications

11.12.4 Braile Biomédica Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Braile Biomédica Recent Developments

11.13 Micro Interventional Devices, Incorporated

11.13.1 Micro Interventional Devices, Incorporated Corporation Information

11.13.2 Micro Interventional Devices, Incorporated Business Overview

11.13.3 Micro Interventional Devices, Incorporated Annuloplasty System Product Models, Descriptions and Specifications

11.13.4 Micro Interventional Devices, Incorporated Annuloplasty System Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Micro Interventional Devices, Incorporated Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Annuloplasty System Industry Chain

12.2 Annuloplasty System Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Annuloplasty System Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Annuloplasty System Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Annuloplasty System Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Annuloplasty System Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Abbott (formerly St. Jude Medical)

Sorin Group (now part of LivaNova)

Valtech Cardio (acquired by Edwards Lifesciences)

Labcor Laboratories Ltda.

Micro Interventional Devices, Incorporated

List of Tables

Table 1. Global Annuloplasty System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Annuloplasty System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Annuloplasty System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Annuloplasty System Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Annuloplasty System Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Annuloplasty System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Annuloplasty System Sales by Region (2020-2025) & (K Units)

Table 8. Global Annuloplasty System Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Annuloplasty System Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Annuloplasty System Sales Share by Manufacturers (2020-2025)

Table 12. Global Annuloplasty System Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Annuloplasty System Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Annuloplasty System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Annuloplasty System as of 2024)

Table 16. Global Annuloplasty System Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Annuloplasty System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Annuloplasty System Manufacturing Base and Headquarters

Table 19. Global Annuloplasty System Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Annuloplasty System Sales by Type (2020-2025) & (K Units)

Table 23. Global Annuloplasty System Sales by Type (2026-2031) & (K Units)

Table 24. Global Annuloplasty System Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Annuloplasty System Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Annuloplasty System ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Annuloplasty System Sales by Application (2020-2025) & (K Units)

Table 29. Global Annuloplasty System Sales by Application (2026-2031) & (K Units)

Table 30. Annuloplasty System High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Annuloplasty System Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Annuloplasty System Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Annuloplasty System ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Annuloplasty System Growth Accelerators and Market Barriers

Table 37. North America Annuloplasty System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Annuloplasty System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Annuloplasty System Growth Accelerators and Market Barriers

Table 40. Europe Annuloplasty System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Annuloplasty System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Annuloplasty System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Annuloplasty System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Annuloplasty System Growth Accelerators and Market Barriers

Table 45. Southeast Asia Annuloplasty System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Annuloplasty System Investment Opportunities and Key Challenges

Table 47. Central and South America Annuloplasty System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Annuloplasty System Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Annuloplasty System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Edwards Lifesciences Corporation Information

Table 51. Edwards Lifesciences Description and Major Businesses

Table 52. Edwards Lifesciences Product Models, Descriptions and Specifications

Table 53. Edwards Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Edwards Lifesciences Sales Value Proportion by Product in 2024

Table 55. Edwards Lifesciences Sales Value Proportion by Application in 2024

Table 56. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024

Table 57. Edwards Lifesciences Annuloplasty System SWOT Analysis

Table 58. Edwards Lifesciences Recent Developments

Table 59. Medtronic Corporation Information

Table 60. Medtronic Description and Major Businesses

Table 61. Medtronic Product Models, Descriptions and Specifications

Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Medtronic Sales Value Proportion by Product in 2024

Table 64. Medtronic Sales Value Proportion by Application in 2024

Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024

Table 66. Medtronic Annuloplasty System SWOT Analysis

Table 67. Medtronic Recent Developments

Table 68. Abbott (formerly St. Jude Medical) Corporation Information

Table 69. Abbott (formerly St. Jude Medical) Description and Major Businesses

Table 70. Abbott (formerly St. Jude Medical) Product Models, Descriptions and Specifications

Table 71. Abbott (formerly St. Jude Medical) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Abbott (formerly St. Jude Medical) Sales Value Proportion by Product in 2024

Table 73. Abbott (formerly St. Jude Medical) Sales Value Proportion by Application in 2024

Table 74. Abbott (formerly St. Jude Medical) Sales Value Proportion by Geographic Area in 2024

Table 75. Abbott (formerly St. Jude Medical) Annuloplasty System SWOT Analysis

Table 76. Abbott (formerly St. Jude Medical) Recent Developments

Table 77. Sorin Group (now part of LivaNova) Corporation Information

Table 78. Sorin Group (now part of LivaNova) Description and Major Businesses

Table 79. Sorin Group (now part of LivaNova) Product Models, Descriptions and Specifications

Table 80. Sorin Group (now part of LivaNova) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Sorin Group (now part of LivaNova) Sales Value Proportion by Product in 2024

Table 82. Sorin Group (now part of LivaNova) Sales Value Proportion by Application in 2024

Table 83. Sorin Group (now part of LivaNova) Sales Value Proportion by Geographic Area in 2024

Table 84. Sorin Group (now part of LivaNova) Annuloplasty System SWOT Analysis

Table 85. Sorin Group (now part of LivaNova) Recent Developments

Table 86. Boston Scientific Corporation Information

Table 87. Boston Scientific Description and Major Businesses

Table 88. Boston Scientific Product Models, Descriptions and Specifications

Table 89. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Boston Scientific Sales Value Proportion by Product in 2024

Table 91. Boston Scientific Sales Value Proportion by Application in 2024

Table 92. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 93. Boston Scientific Annuloplasty System SWOT Analysis

Table 94. Boston Scientific Recent Developments

Table 95. Valtech Cardio (acquired by Edwards Lifesciences) Corporation Information

Table 96. Valtech Cardio (acquired by Edwards Lifesciences) Description and Major Businesses

Table 97. Valtech Cardio (acquired by Edwards Lifesciences) Product Models, Descriptions and Specifications

Table 98. Valtech Cardio (acquired by Edwards Lifesciences) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Valtech Cardio (acquired by Edwards Lifesciences) Recent Developments

Table 100. NeoChord Corporation Information

Table 101. NeoChord Description and Major Businesses

Table 102. NeoChord Product Models, Descriptions and Specifications

Table 103. NeoChord Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. NeoChord Recent Developments

Table 105. Corcym Corporation Information

Table 106. Corcym Description and Major Businesses

Table 107. Corcym Product Models, Descriptions and Specifications

Table 108. Corcym Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Corcym Recent Developments

Table 110. Labcor Laboratories Ltda. Corporation Information

Table 111. Labcor Laboratories Ltda. Description and Major Businesses

Table 112. Labcor Laboratories Ltda. Product Models, Descriptions and Specifications

Table 113. Labcor Laboratories Ltda. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Labcor Laboratories Ltda. Recent Developments

Table 115. AFFLUENT MEDICAL Corporation Information

Table 116. AFFLUENT MEDICAL Description and Major Businesses

Table 117. AFFLUENT MEDICAL Product Models, Descriptions and Specifications

Table 118. AFFLUENT MEDICAL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. AFFLUENT MEDICAL Recent Developments

Table 120. Valcare Medical Corporation Information

Table 121. Valcare Medical Description and Major Businesses

Table 122. Valcare Medical Product Models, Descriptions and Specifications

Table 123. Valcare Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Valcare Medical Recent Developments

Table 125. Braile Biomédica Corporation Information

Table 126. Braile Biomédica Description and Major Businesses

Table 127. Braile Biomédica Product Models, Descriptions and Specifications

Table 128. Braile Biomédica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Braile Biomédica Recent Developments

Table 130. Micro Interventional Devices, Incorporated Corporation Information

Table 131. Micro Interventional Devices, Incorporated Description and Major Businesses

Table 132. Micro Interventional Devices, Incorporated Product Models, Descriptions and Specifications

Table 133. Micro Interventional Devices, Incorporated Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Micro Interventional Devices, Incorporated Recent Developments

Table 135. Key Raw Materials Distribution

Table 136. Raw Materials Key Suppliers

Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 138. Milestones in Production Technology Evolution

Table 139. Distributors List

Table 140. Market Trends and Market Evolution

Table 141. Market Drivers and Opportunities

Table 142. Market Challenges, Risks, and Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Annuloplasty System Product Picture

Figure 2. Global Annuloplasty System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Mitral Valve Repair Product Picture

Figure 4. Tricuspid Valve Repair Product Picture

Figure 5. Aortic Valve Repair Product Picture

Figure 6. Global Annuloplasty System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Hospitals

Figure 8. Ambulatory Surgical Centers

Figure 9. Others

Figure 10. Annuloplasty System Report Years Considered

Figure 11. Global Annuloplasty System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 13. Global Annuloplasty System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Annuloplasty System Revenue Market Share by Region (2020-2031)

Figure 15. Global Annuloplasty System Sales (2020-2031) & (K Units)

Figure 16. Global Annuloplasty System Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global Annuloplasty System Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers Annuloplasty System Sales Volume Market Share in 2024

Figure 19. Global Annuloplasty System Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Mitral Valve Repair Revenue Market Share by Manufacturer in 2024

Figure 22. Tricuspid Valve Repair Revenue Market Share by Manufacturer in 2024

Figure 23. Aortic Valve Repair Revenue Market Share by Manufacturer in 2024

Figure 24. Global Annuloplasty System Sales Market Share by Type (2020-2031)

Figure 25. Global Annuloplasty System Revenue Market Share by Type (2020-2031)

Figure 26. Global Annuloplasty System Sales Market Share by Application (2020-2031)

Figure 27. Global Annuloplasty System Revenue Market Share by Application (2020-2031)

Figure 28. North America Annuloplasty System Sales YoY (2020-2031) & (K Units)

Figure 29. North America Annuloplasty System Revenue YoY (2020-2031) & (US$ Million)

Figure 30. North America Top 5 Manufacturers Annuloplasty System Sales Revenue (US$ Million) in 2024

Figure 31. North America Annuloplasty System Sales Volume (K Units) by Type (2020- 2031)

Figure 32. North America Annuloplasty System Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 33. North America Annuloplasty System Sales Volume (K Units) by Application (2020-2031)

Figure 34. North America Annuloplasty System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 35. US Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 36. Canada Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 37. Mexico Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 38. Europe Annuloplasty System Sales YoY (2020-2031) & (K Units)

Figure 39. Europe Annuloplasty System Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Europe Top 5 Manufacturers Annuloplasty System Sales Revenue (US$ Million) in 2024

Figure 41. Europe Annuloplasty System Sales Volume (K Units) by Type (2020-2031)

Figure 42. Europe Annuloplasty System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 43. Europe Annuloplasty System Sales Volume (K Units) by Application (2020-2031)

Figure 44. Europe Annuloplasty System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. Germany Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 46. France Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 47. U.K. Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 48. Italy Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 49. Russia Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Annuloplasty System Sales YoY (2020-2031) & (K Units)

Figure 51. Asia-Pacific Annuloplasty System Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Top 8 Manufacturers Annuloplasty System Sales Revenue (US$ Million) in 2024

Figure 53. Asia-Pacific Annuloplasty System Sales Volume (K Units) by Type (2020- 2031)

Figure 54. Asia-Pacific Annuloplasty System Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 55. Asia-Pacific Annuloplasty System Sales Volume (K Units) by Application (2020-2031)

Figure 56. Asia-Pacific Annuloplasty System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Indonesia Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 58. Japan Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 59. South Korea Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 60. China Taiwan Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 61. India Annuloplasty System Revenue (2020-2031) & (US$ Million)

Figure 62. Central and South America Annuloplasty System Sales YoY (2020-2031) & (K Units)

Figure 63. Central and South America Annuloplasty System Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Central and South America Top 5 Manufacturers Annuloplasty System Sales Revenue (US$ Million) in 2024

Figure 65. Central and South America Annuloplasty System Sales Volume (K Units) by Type (2021-2031)

Figure 66. Central and South America Annuloplasty System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 67. Central and South America Annuloplasty System Sales Volume (K Units) by Application (2020-2031)

Figure 68. Central and South America Annuloplasty System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Brazil Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 70. Argentina Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 71. Middle East, and Africa Annuloplasty System Sales YoY (2020-2031) & (K Units)

Figure 72. Middle East and Africa Annuloplasty System Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Middle East and Africa Top 5 Manufacturers Annuloplasty System Sales Revenue (US$ Million) in 2024

Figure 74. Middle East and Africa Annuloplasty System Sales Volume (K Units) by Type (2021-2031)

Figure 75. South America Annuloplasty System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Middle East and Africa Annuloplasty System Sales Volume (K Units) by Application (2020-2031)

Figure 77. Middle East and Africa Annuloplasty System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. GCC Countries Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 79. Turkey Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 80. Egypt Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 81. South Africa Annuloplasty System Revenue (2020-2025) & (US$ Million)

Figure 82. Annuloplasty System Industry Chain Mapping

Figure 83. Regional Annuloplasty System Manufacturing Base Distribution (%)

Figure 84. Global Annuloplasty System Production Market Share by Region (2020-2031)

Figure 85. Annuloplasty System Production Process

Figure 86. Regional Annuloplasty System Production Cost Structure

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Y16200

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Z16493

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions